Creo Medical Group PLC (AIM:CREO)

London flag London · Delayed Price · Currency is GBP · Price in GBX
15.13
0.00 (0.00%)
Feb 27, 2026, 4:18 PM GMT
1.65%
Market Cap 60.87M
Revenue (ttm) 4.60M
Net Income (ttm) 500.00K
Shares Out 402.47M
EPS (ttm) -0.00
PE Ratio 68.59
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 259,844
Average Volume 1,021,460
Open 15.25
Previous Close 15.13
Day's Range 15.00 - 15.50
52-Week Range 9.22 - 18.50
Beta 0.54
RSI 48.06
Earnings Date May 13, 2026

About Creo Medical Group

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develps CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope. The company also offers Speedboat Inject, an energy multimodal instrument for endoscopy; MicroBlate Fine, a microwave needl... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2003
Employees 129
Stock Exchange London Stock Exchange AIM
Ticker Symbol CREO
Full Company Profile

Financial Performance

In 2024, Creo Medical Group's revenue was 4.00 million, a change of 0.00% compared to the previous year's 4.00 million. Losses were -28.70 million, 32.3% more than in 2023.

Financial Statements

News

Creo Medical Group PLC (CMEOF) Q2 2025 Earnings Call Transcript

Creo Medical Group PLC (OTCPK:CMEOF) Q2 2025 Earnings Call September 24, 2025 11:00 AM EDTCompany ParticipantsCraig Gulliford - CEO & Executive...

5 months ago - Seeking Alpha